Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction
Conclusions: The ability to improve symptoms and LVEF in unfit cancer patients makes ivabradine a reasonable pharmacological tool for treating CTrLVD.Chemotherapy 2018;63:315 –320
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Cardiovascular | Chemotherapy | Heart | Heart Failure | Study